EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Regional News

Biohaven taps Pfizer for global Nurtec push in deal worth up to $1.24B

Since scoring an FDA approval earlier this year to both treat and prevent migraine, Biohaven’s Nurtec ODT has jumped out ahead of Big Pharma rival AbbVie in garnering...
Continue Reading →
Regional News

What would Medicare price negotiations bring to the US? Look to Europe, Lilly CEO Ricks says

When posed with the decades-old question of how drug price reform would affect their operations in the U.S., pharma execs have a ready-made response: Reducing drug pr...
Continue Reading →
Regional News

Amid new pricing pressure, Lilly cuts cost of generic insulin by another 40%

With drugmakers facing renewed calls to lower the cost of prescription drugs, Eli Lilly has taken preemptive action, dropping the cost of its generic insulin by 40%. ...
Continue Reading →
Regional News

Amid COVID’s latest surge, Regeneron and Eli Lilly score new antibody supply deals with the U.S.

During a call with analysts last month, Regeneron said it didn’t expect to record additional sales of its COVID-19 antibodies to the United States this year. But les...
Continue Reading →
Regional News

CEOs of AbbVie, BMS, Lilly, GSK and more raise concerns about Washington’s intensifying drug-pricing push

As officials in Washington weigh contentious drug-pricing measures, there's even more evidence that pharma companies are worried about potential reform. In an open l...
Continue Reading →
Regional News

Eli Lilly’s Olympic run ends with enduring stories of Team USA athletes’ sport and health quests

Eli Lilly’s Olympic sponsorship ended last week with millions of media impressions, bolstered corporate pride and even a gold medal for one of its athletes. Volleybal...
Continue Reading →
Catalyst: 12th January 2026
Quotient